SCHEMBL11007131

SCHEMBL11007131

Nc1n[c]nc2[nH]c(Cl)nc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4351099 0.76 ADORA3 (0.35) —
SCHEMBL7526936 0.71 CDK1 (0.35) —
SCHEMBL842439 0.69 ADORA2A (0.40) —
SCHEMBL11007134 0.68 — —
SCHEMBL10912530 0.68 KDM4E (0.33) —
SCHEMBL6153814 0.63 — —
SCHEMBL3158626 0.63 CHUK (0.36) —
SCHEMBL442759 0.61 PNP (0.32) —
SCHEMBL9208924 0.60 — —
SCHEMBL839588 0.57 XDH (0.53) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4558047-A ANTITUMOR AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-12-10 — — US disclosed
Send feedback